Cancer remains a significant global health challenge, with chronic inflammation often contributing in tumor development and progression. , Therefore, the search for novel anti-inflammatory agents to complement conventional cancer therapies is crucial. Triiptolide, a synthetic derivative of the natural product triptolide, has emerged as a promising

Barzolvolimab: A New Possibility for Inflammatory Diseases? Barzolvolimab, a recently discovered biological compound, is sparking substantial attention within the research field. This groundbreaking molecule functions as a effective inhibitor of immune 17F cytokine, a crucial factor in the progression of various chronic ailments, including psorias